Cosciens Biopharma Files 6-K Report
Ticker: CSCIF · Form: 6-K · Filed: May 2, 2025 · CIK: 1113423
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-name-change
TL;DR
Cosciens Biopharma (fka Aeterna Zentaris) filed a 6-K on May 2nd, confirming 20-F reporting.
AI Summary
Cosciens Biopharma Inc. filed a Form 6-K on May 2, 2025, reporting as a foreign private issuer. The company, formerly known as Aeterna Zentaris Inc. and Aeterna Laboratories Inc., is incorporated in A6 and has its principal executive offices in Toronto, Canada. This filing is for the month of May 2025 and indicates the company files annual reports under Form 20-F.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Cosciens Biopharma's status as a foreign private issuer and its reporting obligations.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically increase risk.
Key Numbers
- 20250502 — Filing Date (Date of the 6-K submission)
Key Players & Entities
- COSCIENS Biopharma Inc. (company) — Filer
- Aeterna Zentaris Inc. (company) — Former company name
- AETERNA LABORATORIES INC (company) — Former company name
- Norton Rose Fulbright Canada, LLP (company) — Legal counsel/address provider
- 001-38064 (dollar_amount) — SEC File Number
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information that the issuer publicly discloses or is required to disclose in its home country.
What were the previous names of Cosciens Biopharma Inc.?
Cosciens Biopharma Inc. was formerly known as Aeterna Zentaris Inc. and Aeterna Laboratories Inc.
What is the SEC file number for Cosciens Biopharma Inc.?
The SEC file number for Cosciens Biopharma Inc. is 001-38064.
Where are the principal executive offices of Cosciens Biopharma Inc. located?
The principal executive offices are located in Toronto, Canada, c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7.
Does Cosciens Biopharma Inc. file annual reports under Form 20-F or 40-F?
Cosciens Biopharma Inc. indicated that it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 2, 2025 regarding COSCIENS Biopharma Inc. (CSCIF).